Literature DB >> 36060320

Noradrenergic Pheochromocytoma: A Case Report.

Mohammed Amine Essafi1, Sanae Habibi1, Hayat Aynaou1, Houda Salhi1, Hanan El Ouahabi1.   

Abstract

Pheochromocytomas and paragangliomas are rare neuroendocrine tumors developed from chromaffin cells. They are exceptional in children with an atypical symptomatology. We report here a case of a 17-year-old boy who presented with a left retroperitoneal mass discovered on thoracic-abdominal-pelvic computed tomography (CT) scan in the presence of diffuse abdominal pain, more pronounced in the left hypochondrium. The exploration had objectified an exclusive secretion of urinary normetanephrine over 24 hours. Metanephrine and 3 ortho methyldopamine were within normal limits. He had adrenalectomy after controlling his blood pressure with an alpha blocker. Histology had confirmed a pheochromocytoma of non-aggressive potential Pheochromocytoma of the Adrenal gland Scaled Score (PASS) 2. The evolution was favorable with normalization of blood pressure and urinary catecholamines at one week, three months, six months, and one year. He tested negative for hereditary syndromic including Von Hippel-Lindau (VHL), RET genes, subject to the succinate dehydrogenase complex B and D subunit genes (SDHB-D), which have been requested.
Copyright © 2022, Essafi et al.

Entities:  

Keywords:  adolescent; adrenals; normetanephrine; paraganglioma; pheochromocytoma

Year:  2022        PMID: 36060320      PMCID: PMC9424061          DOI: 10.7759/cureus.27492

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  7 in total

1.  Germ-line mutations in nonsyndromic pheochromocytoma.

Authors:  Hartmut P H Neumann; Birke Bausch; Sarah R McWhinney; Bernhard U Bender; Oliver Gimm; Gerlind Franke; Joerg Schipper; Joachim Klisch; Carsten Altehoefer; Klaus Zerres; Andrzej Januszewicz; Charis Eng; Wendy M Smith; Robin Munk; Tanja Manz; Sven Glaesker; Thomas W Apel; Markus Treier; Martin Reineke; Martin K Walz; Cuong Hoang-Vu; Michael Brauckhoff; Andreas Klein-Franke; Peter Klose; Heinrich Schmidt; Margarete Maier-Woelfle; Mariola Peçzkowska; Cesary Szmigielski; Charis Eng
Journal:  N Engl J Med       Date:  2002-05-09       Impact factor: 91.245

Review 2.  Perioperative Management of Pheochromocytoma.

Authors:  Julian Naranjo; Sarah Dodd; Yvette N Martin
Journal:  J Cardiothorac Vasc Anesth       Date:  2017-02-04       Impact factor: 2.628

3.  Discrepancy between PNMT presence and relative lack of adrenaline production in extra-adrenal pheochromocytoma.

Authors:  H Funahashi; T Imai; Y Tanaka; J Tobinaga; M Wada; T Matsuyama; K Tsukamura; F Yamada; H Takagi; T Narita
Journal:  J Surg Oncol       Date:  1994-11       Impact factor: 3.454

4.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

Authors:  Jacques W M Lenders; Quan-Yang Duh; Graeme Eisenhofer; Anne-Paule Gimenez-Roqueplo; Stefan K G Grebe; Mohammad Hassan Murad; Mitsuhide Naruse; Karel Pacak; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2014-06       Impact factor: 5.958

5.  The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma.

Authors:  Y Ito; Y Fujimoto; T Obara
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

Review 6.  Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.

Authors:  Jacques W M Lenders; Michiel N Kerstens; Laurence Amar; Aleksander Prejbisz; Mercedes Robledo; David Taieb; Karel Pacak; Joakim Crona; Tomáš Zelinka; Massimo Mannelli; Timo Deutschbein; Henri J L M Timmers; Frederic Castinetti; Henning Dralle; Jřri Widimský; Anne-Paule Gimenez-Roqueplo; Graeme Eisenhofer
Journal:  J Hypertens       Date:  2020-08       Impact factor: 4.844

7.  Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?

Authors:  Eric Grouzmann; Oliver Tschopp; Frédéric Triponez; Maurice Matter; Stefan Bilz; Michael Brändle; Tilman Drechser; Sarah Sigrist; Henryk Zulewski; Christoph Henzen; Stefan Fischli; Karim Abid
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.